HSBC AKT.ANL. 12/24 GLJ/ DE000HS0UD11 /
2024-05-31 1:40:12 PM | Chg.-1.330 | Bid2:15:00 PM | Ask2:15:00 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
87.810EUR | -1.49% | 87.800 Bid Size: 100,000 |
87.950 Ask Size: 100,000 |
GRENKE AG NA O.N. | 25.00 EUR | 2024-12-30 | Call |
Newsfile Corp
2:11 PM
Funded Capital Launches Revolutionary Financing Program for Ground-Up Constructions, Offering 100% F...
Newsfile Corp
2:08 PM
Abitibi Metals Corp to Participate in THE Mining Investment Event of the North, Canada's Only Tier I...
GlobeNewswire
2:05 PM
Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
2:00 PM
Haoxi Health Technology Limited Reports Unaudited Financial Results for The Six Months Ended Decembe...
GlobeNewswire
2:00 PM
Generation Lab Introduces First Platform that Measures Aging & Treatment Efficacy to Help Extend the...
GlobeNewswire
2:00 PM
Autolus Therapeutics presents longer-term follow-up and additional data analysis of Pivotal Phase 2 ...
GlobeNewswire
2:00 PM
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 i...
GlobeNewswire
2:00 PM
Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference
GlobeNewswire
2:00 PM
Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire
2:00 PM
PodcastOne (Nasdaq: PODC) Appoints Wall Street Veteran Jon Merriman to Its Board of Directors
GlobeNewswire
2:00 PM
ABM Named Among Barron’s 100 Most Sustainable Companies for Second Consecutive Year
GlobeNewswire
2:00 PM
Iterum Therapeutics Receives FDA Acceptance of Resubmission of NDA for Oral Sulopenem for the treatm...